Adjust Text Size

In the News

« Back Garden City - November 1, 2018

Dr. Mark Fleckner Honored with Patients' Choice and Compassionate Doctor Awards

Dr. Mark Fleckner, a Garden City ophthalmologist specializing in retinal diseases, has been recognized as a "Patients' Choice" physician and "Compassionate Doctor" based on online patient reviews.

According to, a physician rating website that features the awards, Compassionate Doctor certification "is granted to physicians who treat their patients with the utmost kindness. The honor is granted based on a physician's overall and bedside manner scores."

Patients' Choice recognition "reflects the difference a particular physician has made in the lives of his/her patients," according to "The honor is bestowed to physicians who have received near perfect scores, as voted by patients."

"I am honored to have received this recognition from my patients," said Dr. Fleckner. "We strive to provide high quality and compassionate care, and we are pleased to be achieving our goals."

Dr. Mark Fleckner is a Board certified ophthalmologist, specializing in the treatment of diabetic eye disease, macular degeneration and other diseases of the retina. He completed a two-year fellowship in vitreoretinal diseases and surgery at the Massachusetts Eye and Ear Infirmary/Harvard University. He also completed a two-year postgraduate research fellowship at Schepens Eye Research Institute in Boston.

Dr. Fleckner is a diplomate of the American Board of Ophthalmology and the National Board of Medical Examiners, and a Fellow of the American Academy of Ophthalmology and the American Medical Association.

He is affiliated with Winthrop University Hospital and Mercy Medical Center and Nassau University Medical Center.

He also sees patients in an office in Fresh Meadows, Queens. For more information about eye diseases and Dr. Fleckner, visit

Garden City / Fresh Meadows Opthalmologist Dr. Mark Fleckner Facebook YouTube interview with Fresh Meadows Opthalmologist Dr. Mark Fleckner

Copyright © 2012 - 2021 / all rights reserved / Disclaimer

site designed and maintained by Target Group Media